Investor Presentation

Here's the concise, retail-friendly summary: **1. Business Performance:** Amrutanjan Health Care posted strong Q3 net sales of 141.04 Cr (+14.9%) and YTD sales of 352.78 Cr (+11.5%). Pain Management (Amrutanjan) and Women's Hygiene (Comfy) drove growth; Comfy's Q3 sales rose 22.6%, boosted by XL variants. **2. Growth Drivers or Strategy:** The company targets deeper market penetration and sales network expansion.

This includes increased TV/digital media spending for awareness and rural van initiatives to expand reach. **3. Recent Developments:** AHCL launched Comfy Slimfit XXL Night Pads in Q3, broadening offerings.

Distribution expanded with 40,000 new outlets. **4. Key Financial Metrics:** Q3 PBT was 26.36 Cr (+1.4%), PAT 19.45 Cr (+1.0%). YTD, PBT jumped 17.8% to 56.87 Cr, and PAT 17.0% to 41.73 Cr. **5. Management Commentary / Outlook:** Management credits strong execution for double-digit revenue/profit growth.

Power brands (Amrutanjan, Comfy, Relief, Electro+) should drive health & wellness market share, with sustained double-digit growth projected for Q4.